Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of α1-noradrenergic receptors demonstrated by in vivo voltammetry

Brain Research

Volumn 460, Issue 2, 1988, Pages 398-401

  Lane, Ross F ^a   Blaha, Charles D ^a   Rivet, Jean Michel ^a  

^a UNIVERSITY OF OREGON   (United States)

Author keywords

Chronic treatment; Clozapine; Dopamine release; In vivo voltammetry; Nucleus accumbens; Prazosin; Striatum; 1 Noradrenergic antagonist

Indexed keywords

CLOZAPINE; HALOPERIDOL; PRAZOSIN;

ANIMAL EXPERIMENT; CORPUS STRIATUM; DOPAMINE RELEASE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; POTENTIOMETRY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; APOMORPHINE; CLOZAPINE; CORPUS STRIATUM; DIBENZAZEPINES; DOPAMINE; HALOPERIDOL; LIMBIC SYSTEM; MALE; NUCLEUS ACCUMBENS; PRAZOSIN; RATS; RATS, INBRED STRAINS; RECEPTORS, ADRENERGIC, ALPHA; REFERENCE VALUES; SEPTAL NUCLEI; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023755323     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(88)90390-3     Document Type: Article

References (29)

1. Chemically modified electrode for in vivo monitoring of brain catecholamines
2. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo
3. Application of in vivo electrochemistry to cholecystokinin-dopamine interactions in the ventral striatum
4. Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity
5. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
6. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons
7. Neuroleptics and psychotic disorders
8. Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism
9. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording
10. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology
11. Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study
12. Electrochemistry in vivo: application to CNS pharmacology
13. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens
14. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action
15. Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment
16. Electrochemistry in vivo: monitoring dopamine release in the brain of the conscious, freely moving rat
17. Release of cortical catecholamines by visual stimulation requires activity in thalamocortical afferents of monkey and cat
18. Nucleus accumbens and schizophrenia
19. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs
20. Comparative effects of clozapine and alpha-adrenoceptor blocking drugs on regional noradrenaline metabolism in rat brain
21. Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic, and histamine receptors to clinical potency
22. 2-adrenergic receptor affinity states in bovine caudate nucleus
23. 2-adrenoceptors in the regulation of striatal dopaminergic transmission
24. Neuroleptics and the limbic system
25. Drugs, neurotransmitters and schizophrenia
26. Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat
27. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons